Background : HPV-related oropharyngeal squamous cell carcinoma (OSCC) seems to be more responsive to chemotherapy and radiation than diseases unrelated to HPV. Therefore, it is accepted that HPV testing plays an important role as a biomarker in the management of patients with OSCC. Purpose: We aimed to find an optimal HPV detection algorithm using formalin-fixed paraffin embedded (FFPE) specimens. Methods: Archival biopsies from 68 patients with OSCC were evaluated. HPV DNA was detected by polymerase chain reaction (PCR) for HPV16, 18, 31, 35, 51, 52, 58,
in situ hybridization (ISH) was performed for HPV16 or 18, and p16 was detected by immunohistochemistry (p16-IHC). Results : Of the 68 samples, HPV was positive in 25 by PCR (36.8%), 22 by ISH (32.4%), and p16 was overexpressed in 30 samples (44.1%). We defined that samples positive by more than two methods (PCR, ISH and/or p16-IHC) were HPV positive. The sensitivity, specificity, positive predictive value and negative predictive value were : 92%, 93%, 88% and 95% for PCR, 92%, 100%, 100% and 96% for ISH, 100%, and 86%, 80% and 100% for p16-IHC, respectively. Conclusion : We recommend that OSCC patients should undergo tumor evaluation for p16-IHC as a screening test and then HPV determination, preferably using an ISH assay.
View full abstract